Contributor:

Optimizing the Surface

Chris Starr, MD; Douglas K. Devries, OD; Preeya Gupta, MD; and Leslie E. O’Dell, OD, FAAO

Collaborating With an OG OD

Marc R. Bloomenstein, OD, FAAO; and Douglas K. Devries, OD

Combining Technologies for a Complex Case

Chris Starr, MD; Douglas K. Devries, OD; Preeya Gupta, MD; and Leslie E. O’Dell, OD, FAAO

Maximizing Quality of Life

Chris Starr, MD; Douglas K. Devries, OD; Preeya Gupta, MD; and Leslie E. O’Dell, OD, FAAO

Inflammation: The Root of OSD

Douglas Devries, OD

Integrating Point-of-Care Testing

Douglas K. Devries, OD

Let's Talk Debridement

Douglas K. Devries, OD, Marc Bloomenstein, OD, FAAO

First-Line Treatment for Meibomian Gland Dysfunction

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Advanced Features of the Systane® iLux2® System

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Clinical Data From the Systane® iLux2®System After 1 Year

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Clinical Data From the Systane® iLux2® System

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

What Makes the Systane® iLux2® Different From Traditional Heat Therapy?

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Improve Meibomian Gland Function and Tear Film Stability With Systane® iLux2®

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Case Studies in Treating Ocular Surface Disease: Season 2

Chris Starr, MD; Preeya Gupta, MD; Douglas DeVries, OD; and Leslie O’Dell, OD

How to Diagnose and Treat Nocturnal Lagophthalmos

Jackie Garlich, OD, FAAO, and Leslie O’Dell, OD, FAAO